Charles Schwab Investment Management Inc Voyager Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 137,477 shares of VYGR stock, worth $794,617. This represents 0.0% of its overall portfolio holdings.
Number of Shares
137,477
Previous 134,004
2.59%
Holding current value
$794,617
Previous $1.06 Million
24.08%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding VYGR
# of Institutions
130Shares Held
34.7MCall Options Held
39.7KPut Options Held
34.6K-
Black Rock Inc. New York, NY5.31MShares$30.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$30.1 Million0.5% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$22.6 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$18.4 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$13.2 Million0.07% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $223M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...